Naphtho[1,2-b][1,4]diazepinedione-Based P2X4 Receptor Antagonists from Structure-Activity Relationship Studies toward...

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Molecular Imaging

Background:

• The P2X4 receptor is a key target in neuropathic pain and cancer.
• Developing specific antagonists and imaging agents for P2X4 receptors remains a challenge.

Purpose of the Study:

• To design and synthesize 1,4-naphthodiazepinedione-based P2X4 receptor antagonists.
• To evaluate these compounds for therapeutic potential and as Positron Emission Tomography (PET) tracers for cancer imaging.

Main Methods:

• Structure-activity relationship (SAR) studies combined with molecular docking and dynamics simulations.
• In vitro assays for P2X4 receptor antagonism and interleukin-1β release inhibition.
• Radiolabeling with fluorine-18 and in vivo PET imaging in mice to assess biodistribution and metabolism.

Main Results:

• A series of potent P2X4 receptor antagonists were identified.
• Compounds showed promising in vitro inhibition of interleukin-1β release and suitability for radiolabeling.
• In vivo studies revealed strong receptor binding and serum stability, but rapid metabolism limited PET tracer potential.

Conclusions:

• 1,4-naphthodiazepinedione derivatives show potential as P2X4 receptor antagonists for therapeutic applications.
• Significant challenges exist in developing metabolically stable PET tracers for P2X4 receptor imaging.
• Further structural optimization is required to overcome in vivo metabolic limitations for PET tracer development.